Ideagen PLC Director/PDMR Shareholding (8913W)

TIDMIDEA

RNS Number : 8913W

Ideagen PLC

13 December 2019

Ideagen PLC

("Ideagen," "the Company" or the "Group")

Director Dealing

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that Alan Carroll, a non-executive director, has purchased 93 ordinary shares of 1p each in the Company ('Ordinary Shares') at a price of 169.9 pence each (the 'Purchase') as a result of the automatic reinvestment of the Company's recent dividend by his nominated broker.

In addition, Mr Carroll sold 11,566 Ordinary Shares at a price of 168.0 pence each and purchased 11,566 shares at a price of 168.26 pence into his ISA.

Following the Purchase, Mr Carroll's beneficial interest has increased to 204,264 shares representing approximately 0.1% of the Company's issued ordinary share capital.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

Enquiries:

 
Ideagen plc                          01629 699100 
David Hornsby, Executive Chairman 
Ben Dorks, Chief Executive 
Graeme Spenceley, Finance Director 
 
finnCap Limited                      020 7220 0500 
Henrik Persson/James Thompson 
 (Nomad) 
Alice Lane (ECM) 
Canaccord Genuity                    020 7523 8000 
Simon Bridges 
Richard Andrews 
 

About Ideagen plc

Ideagen is a UK-headquartered, global technology company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

The Group provides software and services to organisations operating within highly regulated industries such as aviation, banking and finance and life science, with its main operational premises spread throughout the UK, EU, US, Middle East and SE Asia.

With an excellent portfolio of software products including Q-Pulse, Coruson, Pentana Audit and PleaseReview, Ideagen helps its clients reduce costs, improve operational efficiency, strengthen compliance and oversight and anticipate and manage every detail of risk.

Currently, more than 4,700 organisations use Ideagen's products including seven of the top 10 UK accounting firms, all of the top aerospace and defence companies and 75% of the world's leading pharmaceutical firms.

Ideagen's diverse and varied customer base includes many well-known, global brands such as British Airways, Aggreko, BAE, Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank, Meggitt, Heineken, Johnson Matthey, Haeco Group and European Central Bank. As well as this, Ideagen counts 180 hospitals across the UK and US amongst its client base.

For further information please visit www.ideagen.com.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1.   Details of the person discharging managerial responsibilities / person closely associated 
 a)   Name                                            Alan Carroll 
     ----------------------------------------------  ----------------------------------------------- 
 2.   Reason for the Notification 
     ----------------------------------------------------------------------------------------------- 
 a)   Position/status                                 Non-executive Director 
     ----------------------------------------------  ----------------------------------------------- 
 b)   Initial notification/Amendment                  Initial notification 
     ----------------------------------------------  ----------------------------------------------- 
 3.   Details of the issuer, emission allowance market participant, auction platform, auctioneer 
       or auction monitor 
     ----------------------------------------------------------------------------------------------- 
 a)   Name                                            Ideagen PLC 
     ----------------------------------------------  ----------------------------------------------- 
 b)   LEI                                             213800KS1MLITOVNYC85 
     ----------------------------------------------  ----------------------------------------------- 
 4.   Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
       each type of transaction; (iii) each date; and (iv) each place where transactions have been 
       conducted 
     ----------------------------------------------------------------------------------------------- 
 a)   Description of the Financial                    Ordinary Shares of 1p each 
       instrument, type of instrument 
     ----------------------------------------------  ----------------------------------------------- 
      Identification code                             GB00B0CM0C50 
     ----------------------------------------------  ----------------------------------------------- 
 b)   Nature of the transaction                       Purchase of shares & Sale and 
                                                       buyback of shares to effect 
                                                       a transfer of shares into ISA 
     ----------------------------------------------  ----------------------------------------------- 
 c)   Price(s) and volume(s)                           Price(s)   Volume(s) 
                                                        169.9p      93 
                                                         168.0p     11,566 
                                                         168.26p    11,566 
                                                                  ---------- 
     ----------------------------------------------  ----------------------------------------------- 
 d)   Aggregated information:                         Automatic reinvestment of recent 
       -- Aggregated volume                            dividend into 93 ordinary shares 
       -- Price                                        at a price of 169.9p. 
                                                       Sale of 11,566 ordinary shares 
                                                       at 168p. Buy back, into ISA, 
                                                       of 11,566 ordinary shares at 
                                                       168.26p 
     ----------------------------------------------  ----------------------------------------------- 
 e)   Date of the transaction                         12 December 2019 
     ----------------------------------------------  ----------------------------------------------- 
 f)   Place of the transaction                        London Stock Exchange (XLON) 
     ----------------------------------------------  ----------------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHFMMMZVFVGLZM

(END) Dow Jones Newswires

December 13, 2019 11:38 ET (16:38 GMT)